VRTS's six‑month total return of -0.2% versus the S&P's -6.8% loss is the standout finding; it demonstrates the stock's defensive bias and suggests that its business model—steady fee income from investment products—offers downside protection when equity markets tumble.
The persistent negative three‑year (-6.2%) and five‑year (-6.5%) annualized returns signal a lingering risk: if interest rates rise further, higher borrowing costs could pressure the firm’s leveraged growth strategy and compress valuation multiples, potentially extending underperformance relative to peers.
The slight decline in institutional ownership (-0.23%) combined with a still‑negative Sharpe ratio hints that smart money may be cautiously trimming exposure; if this trend accelerates, it could precipitate a sharper correction given the stock’s high beta.
The combination of a double‑digit YoY revenue decline and negative three‑year CAGR underscores a deteriorating top line that cannot be offset by EPS growth alone, raising concerns about the sustainability of current valuation multiples.
The negative free‑cash‑flow ratio of -8.9% quantifies a cash drain that could force the firm to raise external capital or curtail dividend payouts; if operating cash flow does not improve, liquidity risk may materialize and pressure share price.
The most striking profitability driver is the net margin jump to 16.7%, which alone would have lifted ROE above 12% even without the leverage increase, signaling that core operations are becoming markedly more profitable.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 14.8 | 16.7 | 0.19 | 4.59 | 11.6 | 3.5 | 3.2 |
| 2024 | 13.6 | 13.5 | 0.23 | 4.45 | 15.1 | 4.8 | 3.0 |
| 2023 | 15.1 | 15.5 | 0.23 | 4.26 | 12.4 | 4.3 | 3.6 |
| 2022 | 14.4 | 13.3 | 0.22 | 4.84 | 16.2 | 5.4 | 3.0 |
| 2021 | 25.1 | 21.4 | 0.25 | 4.75 | 24.8 | 8.8 | 5.3 |
| 2020 | 11.2 | 13.3 | 0.17 | 4.88 | 15.5 | 4.3 | 2.3 |
| 2019 | 14.2 | 17.0 | 0.18 | 4.74 | 28.6 | 4.8 | 3.0 |
| 2018 | 12.0 | 13.7 | 0.19 | 4.56 | 25.4 | 4.8 | 2.6 |
| 2017 | 6.3 | 8.7 | 0.16 | 4.40 | 9.2 | 2.4 | 1.4 |
| 2016 | 15.1 | 15.1 | 0.39 | 2.56 | 26.1 | 7.2 | 5.9 |
| 2015 | 6.9 | 9.2 | 0.44 | 1.69 | 18.9 | 10.7 | 4.1 |
The sharp drop in asset turnover signals that new assets are yielding diminishing incremental sales; if this trend persists, future ROIC could erode toward the cost of capital, undermining current efficiency gains.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 1886 | 0 | 45 | 43 | 95 | -50 |
| 2024 | 1615 | 0 | 47 | 51 | 42 | 6 |
| 2023 | 1596 | 0 | 47 | 39 | 51 | -3 |
| 2022 | 1636 | 0 | 41 | 8 | 33 | 8 |
| 2021 | 1473 | 0 | 46 | 5 | 49 | -3 |
| 2020 | 2098 | 0 | 51 | 9 | 35 | 16 |
| 2019 | 2080 | 0 | 48 | 12 | 35 | 13 |
| 2018 | 1900 | 122 | 46 | 13 | 43 | 125 |
| 2017 | 2228 | 173 | 56 | 9 | 56 | 173 |
| 2016 | 935 | 0 | 41 | 9 | 68 | -219 |
| 2015 | 825 | 0 | 37 | 9 | 61 | -127 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $4291M | $3253M | $934M | $2843M | $2366M | $477M | $581M | $153M |
| 2024 | $3994M | $2986M | $897M | $2474M | $2075M | $400M | $518M | $208M |
| 2023 | $3679M | $2705M | $864M | $2254M | $1913M | $340M | $450M | $147M |
| 2022 | $3953M | $3016M | $817M | $2338M | $1750M | $589M | $688M | $280M |
| 2021 | $3934M | $2959M | $828M | $2300M | $1714M | $586M | $710M | $248M |
| 2020 | $3467M | $2630M | $711M | $2392M | $2058M | $333M | $424M | $80M |
| 2019 | $3205M | $2455M | $676M | $2112M | $1791M | $321M | $396M | $579M |
| 2018 | $2871M | $2169M | $630M | $1949M | $1696M | $254M | $325M | $529M |
| 2017 | $2591M | $1981M | $589M | $1706M | $1472M | $233M | $300M | $149M |
| 2016 | $824M | $465M | $322M | $359M | $276M | $83M | $265M | $123M |
| 2015 | $860M | $276M | $510M | $153M | $55M | $97M | $478M | $111M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $-67M | $-47M | $191M | $-7M | $-74M | $-60M | $-65M |
| 2024 | $2M | $-17M | $75M | $-6M | $-4M | $-45M | $-58M |
| 2023 | $237M | $-130M | $-356M | $-9M | $228M | $-45M | $-52M |
| 2022 | $133M | $-27M | $-102M | $-7M | $126M | $-90M | $-47M |
| 2021 | $666M | $-175M | $-244M | $-6M | $660M | $-57M | $-31M |
| 2020 | $-226M | $9M | $235M | $-1M | $-227M | $-32M | $-23M |
| 2019 | $-37M | $4M | $100M | $-8M | $-44M | $-40M | $-17M |
| 2018 | $-63M | $-121M | $204M | $-12M | $-74M | $-28M | $-14M |
| 2017 | $-183M | $-417M | $750M | $-2M | $-184M | $-8M | $-13M |
| 2016 | $31M | $3M | $-48M | $-2M | $28M | $-234M | $-14M |
| 2015 | $-209M | $-6M | $110M | $-5M | $-214M | $-80M | $-16M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-07-31 · finexus.net